BRIDGET MARTELL
Profile
First Name
: BRIDGET
Middle Name
:
Last Name
: MARTELL
Related Companies
Titles
Company Name
Related People
DIRECTOR
DIRECTOR
RONI APPEL, RONI A. APPEL, KEN A. BERLIN, KENNETH BERLIN, RICHARD BERMAN, VERED BISKER-LEIB, YUVAL CABILLY, FREDRICK COBB, IGOR GITELMAN, ROY GOLAN, MURRAY A. GOLDBERG, ANDRES GUTIERREZ, SAMIR KHLEIF, THOMAS MCKEARN, THOMAS L. MCKEARN, THOMAS MOORE, THOMAS A. MOORE, PINI ORBACH, JAMES PATTON, MARK J. ROSENBLUM, JOHN ROTHMAN, JOHN M. ROTHMAN, DAVID SIDRANSKY, ROBERT SPIEGEL
DIRECTOR
HARDEAN ACHNECK, LEONID BEIGELMAN, LAWRENCE BLATT, LAWRENCE M. BLATT, LESLEY ANN CALHOUN, SUSHMITA CHANDA, MARGARITA CHAVEZ, BRIAN DOWD, JOHN FRY, KATHLEEN GLAUB, K. PETER HIRTH, PETER HIRTH, MATTHEW MCCLURE, PETER MOLDT, CAROLE NEUCHTERLEIN, JACK NIELSEN, CAROLE NUECHTERLEIN, HEATHER PRESTON, LUCINDA QUAN, JAMES SCOPA, JULIAN SYMONS, TOM WOIWODE, MICHAEL YI
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2025-02-11
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2023-10-25
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2023-10-18
D/A
BIOTECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
2022-11-18
D
BIOTECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
2022-11-18
